Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
E
Eads, Jennifer
University of Pennsylvania, Abramson Cancer Center
Neoadjuvant Setting
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jennifer Eads
Ecker, Brett
Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Brett Ecker
Eckhoff, Austin
Duke University
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Austin Eckhoff
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Austin Eckhoff
Eden, Claire
New York-Presbyterian Weill Cornell Medicine New York-Presbyterian Queens Hospital
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Claire Eden
Edge, Stephen
Roswell Park Comprehensive Cancer Center; Jacobs School of Medicine University at Buffalo
Questions and Discussion
Location:Ballroom A
Stephen Edge
Value Based Cancer Care: Where Are We Now?
Location:Ballroom A
Stephen Edge
Value Based Cancer in Surgical Oncology
Location:Ballroom A
Stephen Edge
Edwards, Jacob
University of Michigan
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing
Location:Ballroom B
Jacob Edwards
Egger, Michael
Unversity of Louisville
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Michael Egger
88: Optimal Radiation Dose Intensity: Low- vs. High-Dose in the Neo-Adjuvant Treatment of Locally Advanced Esophageal Cancer
Location:Ballroom B
Michael Egger
Eggermont, Alexander M. M.
University Medical Center Utrecht, Netherlands & Comprehensive Cancer Center Munich, Germany
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Alexander M. M. Eggermont
Egle, Daniel
Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Daniel Egle
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Daniel Egle
Eilber, Fritz
UCLA Health
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma
Location:Ballroom A
Fritz Eilber
Ejaz, Aslam
The Ohio State University
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Aslam Ejaz
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Aslam Ejaz
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Aslam Ejaz
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Aslam Ejaz
P68: The Impact of Digital Inequities on Gastrointestinal Cancer Disparities in the US
Location:SSO HUB: Rare/Metastatic Cancers Zone
Aslam Ejaz
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Location:SSO HUB: Rare/Metastatic Cancers Zone
Aslam Ejaz
Elashoff, David
University of California Los Angeles
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
David Elashoff
Elbahrawy, Mostafa
Montefiore Medical Center/Albert Einstein College of Medicine
P14: ART1, a mono-ADP-ribosyl transferase, is increased by chemotherapy and radiotherapy and is a novel target in colorectal carcinoma.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mostafa Elbahrawy
El-Deiry, Wafik
Legorreta Cancer Center of Brown University
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Wafik El-Deiry
Elhossiny, Ahmed
University of Michigan
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing
Location:Ballroom B
Ahmed Elhossiny
Elleson, Kelly
Moffitt Cancer Center
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Kelly Elleson
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Kelly Elleson
Elmore, Leisha
Hospital of the University of Pennsylvania
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Leisha Elmore
Elsaid, Mohamed
The Ohio State University Department of Biomedical Informatics
P5: Allostatic Load as a New Predictor of Postoperative Complications in Oncology Patients
Location:SSO HUB: Breast & Endocrine Zone
Mohamed Elsaid
Endo, Yutaka
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Yutaka Endo
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Yutaka Endo
Eng, Oliver
University of California, Irvine
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Oliver Eng
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Oliver Eng
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Oliver Eng
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Oliver Eng
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Oliver Eng
PSM Parallel Session
Location:Ballroom B
Oliver Eng
Enomoto, Laura
University of Tennessee Medical Center Knoxville
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Laura Enomoto
Erali, Richard
Wake Forest Baptist Health
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Richard Erali
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Richard Erali
Erhunmwunsee, Loretta
CITY OF HOPE CANCER CENTER
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Loretta Erhunmwunsee
Erickson, Beth
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Beth Erickson
Erinjeri, Joseph
Department of Radiology
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Joseph Erinjeri
Eroglu, Zeynep
Moffitt Cancer Center, Tampa, FL, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Zeynep Eroglu
Erstad, Derek
Baylor College of Medicine
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer
Location:Ballroom A
Derek Erstad
Eskander, Antoine
University of Toronto
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Antoine Eskander
Espat, N Joseph
RWMC-BUSM
Sirtex industry Spotlight Session: Integrating SIR-Spheres into the Continuum of Surgical Treatment
Location:SSO HUB Theater
N Joseph Espat
Esserman, Laura
UCSF
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2
Location:Veterans Memorial Auditorium
Laura Esserman
Essner, Richard
Saint John's cancer institute
P47: Predicting recurrence after a negative sentinel lymph node in melanoma: the model changes with time and sites of recurrence
Location:SSO HUB: Melanoma & Sarcoma Zone
Richard Essner
Estrella, Jeannelyn
The University of Texas MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Jeannelyn Estrella
Ethun, Cecilia
UT Southwestern
Meet the Experts - HPB Malignancies
Location:Ballroom A
Cecilia Ethun
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Cecilia Ethun
Eton, Omar
Hartford Health Care
Merck Industry Forum: An Adjuvant Treatment Option for Certain Stages of Melanoma
Location:Room 302
Omar Eton
Evans, Douglas
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Douglas Evans
Evans, Elizabeth
Vaccinex, Inc.
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Elizabeth Evans
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Elizabeth Evans
Ewald, Andrew
Department of Cell Biology, School of Medicine, Johns Hopkins University
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers
Location:Ballroom B
Andrew Ewald
Back to Top
